| Detailed information |
|---|
| CancerLivER ID | 2525 |
| Biomarker | Cytoplasmic dynein light chain, Hepatoma-derived growth factor, Ribosomal protein L6, glutathioneS-transferase, Fibronectin, Ras homolog gene family member B, TR3 orphan receptor, c-myc transcription factor (puf), MHC-class IC |
| Biomarker Name/Symbol (given in Publication) | Cytoplasmic dynein light chain (hdle 1), Hepatoma-derived growth factor, Ribosomal protein L6, glutathioneS-transferase, Fibronectin, Ras homolog gene family member B, TR3 orphan receptor, c-myc transcription factor (puf), MHC-class IC |
| Biomolecule | RNAs |
| Subject | Human |
| Degree of Validity | Potential diagnostic marker for HCC and upregulated in HCC than non-tumorous tissue ( with average ratio more than 2); but not validated on independent dataset |
| Experimental Condition | HCC v/s non-tumor |
| Cancer type | Hepatocellular carcinoma |
| Regulation | Upregulated in HCC than non-tumorous tissue ( with average ratio more than 2) |
| Level of significance | NA |
| Source | Tissue |
| PMID | 11283847 |
| Type of Biomarker | Diagnostic |
| Pathway | NA |
| Cohort | Paired HCC and non-tumorous tissues from 10 HCC patients |
| Sensitivity | NA |
| Specificity | NA |
| Accuracy | NA |
| AUC | NA |
| Disease | HCC v/s non-tumor |
| Year of Publication | 2001 |
| Clinical trial | NO |
| Clinical trial (NCT Number) | NA |